Can we decloak how infections drive complications after lung transplantation?

Affiliations

¹ Division of Pulmonary, and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St Louis, Missouri. Electronic address: hkulkarn@wustl.edu.
² Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, Washington.

Editorial

Hrishikesh S Kulkarni et al. J Heart Lung Transplant. 2021 Sep.

. 2021 Sep;40(9):960-962.

doi: 10.1016/j.healun.2021.05.009. Epub 2021 May 29.

¹ Division of Pulmonary, and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St Louis, Missouri. Electronic address: hkulkarn@wustl.edu.
² Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, Washington.

No abstract available

Comment on

Inferior outcomes in lung transplant recipients with serum Pseudomonas aeruginosa specific cloaking antibodies.
Divithotawela C, Pham A, Bell PT, Ledger EL, Tan M, Yerkovich S, Grant M, Hopkins PM, Wells TJ, Chambers DC. Divithotawela C, et al. J Heart Lung Transplant. 2021 Sep;40(9):951-959. doi: 10.1016/j.healun.2021.05.016. Epub 2021 May 30. J Heart Lung Transplant. 2021. PMID: 34226118

1. Lease ED, Zaas DW. Complex bacterial infections pre- and posttransplant. Semin Respir Crit Care Med. 2010;31(2):234–242. doi:10.1055/s-0030-1249119 - DOI - PubMed
1. Belperio J, Palmer SM, Weigt SS. Host-Pathogen Interactions and Chronic Lung Allograft Dysfunction. Ann Am Thorac Soc. 2017;14(Supplement_3):S242–S246. doi:10.1513/AnnalsATS.201606-464MG - DOI - PMC - PubMed
1. Verleden GM, Glanville AR, Lease ED, et al.Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant. Published online April 3, 2019. doi:10.1016/j.healun.2019.03.009 - DOI - PubMed
1. Yamamoto S, Nava RG, Zhu J, et al.Cutting edge: Pseudomonas aeruginosa abolishes established lung transplant tolerance by stimulating B7 expression on neutrophils. J Immunol. 2012;189(9):4221–4225. doi:10.4049/jimmunol.1201683 - DOI - PMC - PubMed
1. Kulkarni HS, Tsui K, Sunder S, et al.Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation. Am J Transplant. 2020;20(4):1028–1038. doi:10.1111/ajt.15687 - DOI - PMC - PubMed